Uses for corticotropin releasing factor atagonists

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/505 (2006.01) A61K 31/435 (2006.01) A61K 31/437 (2006.01) A61K 31/44 (2006.01) A61K 31/506 (2006.01) A61K 31/519 (2006.01) A61K 31/52 (2006.01)

Patent

CA 2189830

Disclosed is a pharmaceutical composition for treating, preventing or inhibiting cardiovascular or heart related diseases, comprising (a) a compound of the formula Image or Image I II or a pharmaceutically acceptable salt thereof, wherein A is N or CR7 (in which R7 is H, alkyl, halo or the like), B is -NR1R2, -CR1 R2R11 or the like (in which R1 is H or alkyl, R2 is alkyl, aryl, arylalkyl, cycloalkyl or the like and R11 is H, OH or the like), D is N, -CR10 (in which R10 is H, alkyl, halo or the like ), C=O, -C=NH, etc.), E is -CR4 (in which R4 is H, alkyl, halo etc.), N, -NR6 or -CR4R6 (in which R4 is H, alkyl, halo, etc. and R6 is H or alkyl), Y is N or CH, Z is O, S, NH, ect., R3 is H, alkyl, halo, etc., R4 is H, alkyl, halo, etc. and R5 is a cyclic group, and (b) a pharmaceutically acceptable diluent or carrier.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Uses for corticotropin releasing factor atagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Uses for corticotropin releasing factor atagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Uses for corticotropin releasing factor atagonists will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2035774

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.